6wcy

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
==N160D Deamidation Mutant of Human gammaD-Crystallin==
==N160D Deamidation Mutant of Human gammaD-Crystallin==
-
<StructureSection load='6wcy' size='340' side='right'caption='[[6wcy]]' scene=''>
+
<StructureSection load='6wcy' size='340' side='right'caption='[[6wcy]], [[Resolution|resolution]] 1.20&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6WCY OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6WCY FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[6wcy]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6WCY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6WCY FirstGlance]. <br>
-
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6wcy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6wcy OCA], [http://pdbe.org/6wcy PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6wcy RCSB], [http://www.ebi.ac.uk/pdbsum/6wcy PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6wcy ProSAT]</span></td></tr>
+
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
 +
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[6w5b|6w5b]]</div></td></tr>
 +
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">CRYGD, CRYG4 ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6wcy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6wcy OCA], [https://pdbe.org/6wcy PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6wcy RCSB], [https://www.ebi.ac.uk/pdbsum/6wcy PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6wcy ProSAT]</span></td></tr>
</table>
</table>
 +
== Disease ==
 +
[[https://www.uniprot.org/uniprot/CRGD_HUMAN CRGD_HUMAN]] Defects in CRYGD are a cause of cataract autosomal dominant (ADC) [MIM:[https://omim.org/entry/604219 604219]]. Cataract is an opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. Cataract is the most common treatable cause of visual disability in childhood.<ref>PMID:9927684</ref> <ref>PMID:10688888</ref> <ref>PMID:21031598</ref> Defects in CRYGD are the cause of cataract congenital non-nuclear polymorphic autosomal dominant (CCP) [MIM:[https://omim.org/entry/601286 601286]]; also known as polymorphic congenital cataract. A congenital cataract characterized by a non-progressive phenotype and partial opacity that has a variable location between the fetal nucleus of the lens and the equator. The fetal nucleus is normal. The opacities are irregular and look similar to a bunch of grapes and may be present simultaneously in different lens layers.<ref>PMID:16943771</ref> <ref>PMID:17564961</ref> Defects in CRYGD are the cause of cataract congenital cerulean type 3 (CCA3) [MIM:[https://omim.org/entry/608983 608983]]; also known as congenital cataract blue dot type 3. A cerulean form of autosomal dominant congenital cataract. Cerulean cataract is characterized by peripheral bluish and white opacifications organized in concentric layers with occasional central lesions arranged radially. The opacities are observed in the superficial layers of the fetal nucleus as well as the adult nucleus of the lens. Involvement is usually bilateral. Visual acuity is only mildly reduced in childhood. In adulthood, the opacifications may progress, making lens extraction necessary. Histologically the lesions are described as fusiform cavities between lens fibers which contain a deeply staining granular material. Although the lesions may take on various colors, a dull blue is the most common appearance and is responsible for the designation cerulean cataract. Defects in CRYGD are the cause of cataract crystalline aculeiform (CACA) [MIM:[https://omim.org/entry/115700 115700]]. A congenital crystalline cataract characterized by fiberglass-like or needle-like crystals projecting in different directions, through or close to the axial region of the lens. The opacity causes a variable degree of vision loss.<ref>PMID:10521291</ref>
 +
== Function ==
 +
[[https://www.uniprot.org/uniprot/CRGD_HUMAN CRGD_HUMAN]] Crystallins are the dominant structural components of the vertebrate eye lens.
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Cataracts involve the deposition of the crystallin proteins in the vertebrate eye lens, causing opacification and blindness. They are associated with either genetic mutation or protein damage that accumulates over the lifetime of the organism. Deamidation of Asn residues in several different crystallins has been observed and is frequently invoked as a cause of cataract. Here, we investigated the properties of Asp variants, deamidation products of gammaD-crystallin, by solution NMR, X-ray crystallography, and other biophysical techniques. No substantive structural or stability changes were noted for all seven Asn to Asp gammaD-crystallins. Importantly, no changes in diffusion interaction behavior could be detected. Our combined experimental results demonstrate that introduction of single Asp residues on the surface of gammaD-crystallin by deamidation is unlikely to be the driver of cataract formation in the eye lens.
 +
 +
Assessing the Structures and Interactions of gammaD-Crystallin Deamidation Variants.,Guseman AJ, Whitley MJ, Gonzalez JJ, Rathi N, Ambarian M, Gronenborn AM Structure. 2020 Nov 23. pii: S0969-2126(20)30418-4. doi:, 10.1016/j.str.2020.11.006. PMID:33264606<ref>PMID:33264606</ref>
 +
 +
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
<div class="pdbe-citations 6wcy" style="background-color:#fffaf0;"></div>
 +
== References ==
 +
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
 +
[[Category: Human]]
[[Category: Large Structures]]
[[Category: Large Structures]]
-
[[Category: Ambarian M]]
+
[[Category: Ambarian, M]]
-
[[Category: Gronenborn AM]]
+
[[Category: Gronenborn, A M]]
-
[[Category: Rathi N]]
+
[[Category: Rathi, N]]
-
[[Category: Whitley MJ]]
+
[[Category: Whitley, M J]]
 +
[[Category: Aging]]
 +
[[Category: Cataract]]
 +
[[Category: Deamidation]]
 +
[[Category: Lens]]
 +
[[Category: Protein modification]]
 +
[[Category: Structural protein]]

Revision as of 06:53, 17 March 2021

N160D Deamidation Mutant of Human gammaD-Crystallin

PDB ID 6wcy

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools